Juan Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared on LinkedIn:
“Beginning August 1, the Cholangiocarcinoma Foundation will accept Letters of Intent for two major grant programs:
- The CCF Innovation Grant
- Career Development Award (CDA)
The 2025 Innovation Award, supported by the Mather Family Foundation, will provide $750,000 over three years for bold clinical trial designs and novel therapies to transform cholangiocarcinoma care.
The CDA offers $300,000 over three years to support mid-career investigators establishing independent research programs in cholangiocarcinoma. Letters of Intent for both opportunities are due by August 22, 2025.
Please visit here for more information and to view the requests for applications.”
More posts featuring Juan W. Valle.